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Spinal cord injury (SCI) triggers profound changes in visceral and somatic targets of sen-
sory neurons below the level of injury. Despite this, little is known about the influence of
injury to the spinal cord on sensory ganglia. One of the defining characteristics of sen-
sory neurons is the size of their cell body: for example, nociceptors are smaller in size
than mechanoreceptors or proprioceptors. In these experiments, we first used a compre-
hensive immunohistochemical approach to characterize the size distribution of sensory
neurons after high- and low-thoracic SCI. Male Wistar rats (300 g) received a spinal cord
transection (T3 or T10) or sham-injury. At 30 days post-injury, dorsal root ganglia (DRGs)
and spinal cords were harvested and analyzed immunohistochemically. In a wide survey of
primary afferents, only those expressing the capsaicin receptor (TRPV1) exhibited somal
hypertrophy after T3 SCI. Hypertrophy only occurred caudal to SCI and was pronounced in
ganglia far distal to SCI (i.e., in L4-S1 DRGs). Injury-induced hypertrophy was accompanied
by a small expansion of central territory in the lumbar spinal dorsal horn and by evidence of
TRPV1 upregulation. Importantly, hypertrophy ofTRPV1-positive neurons was modest after
T10 SCI. Given the specific effects ofT3 SCI onTRPV1-positive afferents, we hypothesized
that these afferents contribute to autonomic dysreflexia (AD). Rats with T3 SCI received
vehicle or capsaicin via intrathecal injection at 2 or 28 days post-SCI; at 30 days, AD was
assessed by recording intra-arterial blood pressure during colo-rectal distension (CRD). In
both groups of capsaicin-treated animals, the severity of AD was dramatically reduced.
While AD is multi-factorial in origin, TRPV1-positive afferents are clearly involved in AD
elicited by CRD. These findings implicate TRPV1-positive afferents in the initiation of AD
and suggest that TRPV1 may be a therapeutic target for amelioration or prevention of AD
after high SCI.
Keywords: capsaicin, colo-rectal distension, dorsal horn, dorsal root, dorsal root ganglion, high blood pressure,
hypertension, hypertrophy
INTRODUCTION
The original formulation of the neurotrophic hypothesis by Ham-
burger and Levi-Montalcini (1949) asserted that the survival of
neurons depends on cues produced in limiting amounts in target
tissues. The subsequent discovery of nerve growth factor (NGF)
as a survival factor for sympathetic and sensory neurons (Cohen
et al., 1954) not only validated this hypothesis, but also extended
the role of neurotrophic factors beyond developmental neuronal
survival: target-derived NGF and numerous other neurotrophic
molecules maintain the phenotype of neurons during adulthood.
This has been arguably best demonstrated in experiments on
primary afferent neurons of the dorsal root ganglion (DRG), a
heterogeneous population of neurons responsible for transmis-
sion of information from the periphery (somatic) and internal
milieu (visceral) to the spinal cord and brainstem.
Early classification of DRG neuronal subsets was based on
cytoplasmic staining with standard histological techniques and
electrophysiological recording followed by dye-filling of neurons
(Willis and Coggeshall, 2004). These methods revealed “small
dark” neurons which have slowly conducting axons (correspond-
ing to thermoceptors and nociceptors, approximately 70% of all
neurons in the DRG), and “large light” cells with rapidly conduct-
ing fibers (30% of all DRG neurons, representing skin and mus-
cle mechanoreceptors). In terms of their neurochemistry, DRG
neurons are remarkably diverse, and much effort has gone into
establishing particular neurochemical phenotypes as functional
proxies (Willis and Coggeshall, 2004). Among the small dark cells,
for example, there are peptidergic and non-peptidergic subtypes,
which also happen to be sensitive to different neurotrophic fac-
tors (NGF, and glial cell line-derived neurotrophic factor, GDNF,
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respectively; Braz et al., 2005). Ascribing functional relevance to
this neurochemical distinction has proven difficult, in part because
both populations express transducers of thermal and noxious
stimuli: one example is the capsaicin-sensitive cation channel tran-
sient receptor potential vanilloid receptor (TRPV1), a remarkably
versatile receptor that is also activated by protons and noxious heat
(Caterina et al., 1997; Tominaga et al., 1998).
Dorsal root ganglia neurons undergo marked changes in neu-
ronal phenotype following their disconnection from their target
tissues by axotomy. Importantly, and in-line with the neurotrophic
hypothesis, these changes are mimicked by depletion of the rele-
vant factors in the absence of axotomy, and reversed by supplying
axotomized neurons with trophic support from exogenous sources
(Rich et al., 1984; Yip et al., 1984; Johnson and Yip, 1985; Wong
and Oblinger, 1991; Matheson et al., 1997; Bennett et al., 1998).
Uninjured DRG neurons undergo hypertrophy following in vivo
delivery of NGF or GDNF (Ramer et al., 2001, 2003). Likewise,
transgenic over-expression of NGF (Goodness et al., 1997) and
the GDNF family member artemin (Elitt et al., 2006) cause sensory
neuronal hypertrophy.
Spinal cord injury (SCI), while not disconnecting DRG neurons
from their peripheral targets, nevertheless has profound effects
on multiple tissues which might be expected to influence neu-
ronal phenotype. Among the most dramatic of these are skeletal
muscle atrophy, and in the lower urinary tract (LUT), detrusor
hypertrophy. In the latter case, increased NGF production by
the bladder has been correlated with hypertrophy of innervat-
ing DRG neurons (Yoshimura, 1999). For complete lesions above
T5/6, SCI is almost always accompanied by cardiovascular dis-
turbances including orthostatic hypotension (OH; a sudden fall
in blood pressure upon assuming an upright position) and auto-
nomic dysreflexia (AD; potentially life-threatening elevations in
blood pressure triggered by sensory stimulation below the injury;
Krassioukov and Claydon, 2006). There is increasing evidence that
blood vessels, a peripheral target of sensory as well as sympathetic
axons, also undergo SCI-induced alterations which may evoke
phenotypic changes in their innervating neurons (McLachlan and
Brock, 2006; Alan et al., 2010; Rummery et al., 2010; Al Dera et al.,
2011; Tripovic et al., 2011).
Here we took a systematic immunohistochemical approach to
studying one of the defining phenotypic features of sensory neu-
rons – soma size – in different populations of sensory neurons
after T3 SCI. We characterized hypertrophy in a specific subset
of nociceptors, those that are sensitive to capsaicin and artemin.
We examined the effect of rostro-caudal level and injury level; we
also examined the density of central projections of hypertrophied
neurons and the role of those neurons in AD. We hypothesized
that SCI would induce nociceptor hypertrophy and/or terminal
sprouting and that these effects would be more pronounced after
high-thoracic injury. After identifying a specific subset of sensory
neurons that responded to SCI, we hypothesized that these would
be involved in induction and/or development of AD.
MATERIALS AND METHODS
SPINAL CORD INJURY SURGERY
Complete transection of the spinal cord at the third (T3) or tenth
(T10) thoracic segments was performed in adult male Wistar
rats (250–350 g, Charles River Laboratories, Inc., Wilmington,
Canada). T3 SCI promotes the development of cardiovascular dys-
function, including AD, while T10 SCI does not. Sham surgeries
were performed at T3 and were identical up to and including
durotomy, without transection of the cord.
Rats were housed in a secure conventional rodent facility, on a
12-h reversed light-dark cycle. The surgical procedures and post-
operative animal care have been described in detail (Ramsey et al.,
2010), but the essential steps are included here.
Animals received prophylactic enrofloxacin (Baytril; 10 mg/kg,
s.c., Associated Veterinary Purchasing; AVP, Langley, Canada)
for 3 days prior to SCI surgery. On the day of surgery, anes-
thesia was induced with ketamine hydrochloride (Vetalar®;
70 mg/kg, i.p., University of McGill Animal Resources Centre,
Montreal, Canada) and medetomidine hydrochloride (Domitor®;
0.5 mg/kg, i.p., AVP). Enrofloxacin (10 mg/kg, s.c.), buprenor-
phine (Temgesic®; 0.02 mg/kg, s.c., McGill University), and keto-
profen (Anafen®, 5 mg/kg, s.c., AVP) were administered pre-
operatively.
After the skin at the surgical site was shaved, scrubbed, and
treated with iodine, the animal was placed in the prone posi-
tion. The spinal cord was exposed via a midline incision in the
skin and superficial muscles, and blunt dissection of the muscles
overlying the C8–T3 (T3 transection) or T8–T11 (T10 transec-
tion) vertebrae. At the T2–T3 intervertebral space or following
a small laminectomy at T9, connective tissues were removed,
the dura was opened and the spinal cord was completely tran-
sected with surgical scissors. Complete transection was verified
by the clear separation and retraction of the cut ends of the
cord, visualized under the surgical microscope. After hemosta-
sis was achieved, the muscle and skin were closed with contin-
uous, 4-0 Vicryl sutures, and interrupted 4-0 Prolene sutures,
respectively.
POST-OPERATIVE ANIMAL CARE
Animals received warmed Lactated Ringer’s solution (5 ml, s.c.)
and recovered in a temperature-controlled environment (Animal
Intensive Care Unit, HotSpot for Birds, Los Angeles, CA, USA).
Anesthesia was reversed with atipamezole hydrochloride (Anti-
sedan; 1 mg/kg, s.c., Novartis, Mississauga, Canada). Enrofloxacin
(10 mg/kg, s.c.), buprenorphine (0.02 mg/kg, s.c.), and ketoprofen
(5 mg/kg, s.c.) were administered once per day for 3 days following
SCI.
Home cages for animals with complete T3 SCI were fitted with
rubber matting (under woodchips, to facilitate movement), low-
reaching water bottles, and food scattered on the cage bottom
to encourage foraging (Ramsey et al., 2010). Animals were sup-
ported with an enriched diet, including meal replacement shake
(Ensure; Abbott, Saint-Laurent, Canada), nutritive transport gel
(Charles River), fruit, cereals, commercially available rat treats
and kibble (LabDiet, Rodent Diet 5001). The bladder was manu-
ally expressed three to four times daily until spontaneous bladder
function returned (about 10 days post-injury). Animal health was
formally monitored daily for the first 2 weeks after SCI and every
2 days thereafter, using objective criteria to assess body weight,
activity level, social behavior,healing at the surgery site,and clinical
signs of morbidity.
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SURVIVAL TIMES
Animals survived for 1 or 3 months after SCI. In our initial exper-
iments examining SCI-induced hypertrophy in the DRG (data
in Figures 1–3 and 5 ), T3 sham-, and spinal cord-injured ani-
mals survived for 3 months. In all subsequent experiments (data
in Figures 4 and 6–8), T3 and T10 sham and spinal cord-injured
animals survived for 1 month following surgery.
INTRATHECAL CAPSAICIN INJECTION
At 48 h (early cap.) or 28 days (late cap.) after SCI, animals were
anesthetized with inhalant isoflurane (AErrane®, AVP; 5% induc-
tion, 2–3% maintenance). The skin overlying the lumbar enlarge-
ment of the spinal cord was shaved, scrubbed, and treated with
iodine. The lumbar enlargement was exposed via midline inci-
sion in the skin and superficial muscles, blunt dissection of deeper
muscles, and a midline laminectomy. Polyurethane tubing (PU,
3 French, Instech, Plymouth Meeting, USA) was introduced sub-
durally and 50µg of capsaicin (Sigma-Aldrich Inc., St. Louis, USA)
in 10µl 50% dimethyl sulfoxide (DMSO; Sigma) was injected
intrathecally. Control animals received 50% DMSO only, at 28 days
after SCI. The muscle and skin were closed with sutures (4-0 Vicryl
and 4-0 Prolene, respectively).
CARDIOVASCULAR ASSESSMENT
Thirty days after SCI, a cannula (PU, 3 French, Instech) was
implanted into the left carotid artery in all animals for contin-
uous beat-to-beat blood pressure recording. Arterial cannulation
was performed under isoflurane anesthesia and the cannula was
tunneled subcutaneously to exit the skin dorsally, through small
incision at the base of the skull. The cannula was filled with a lock
solution of 1:10 heparin (Hepalean®, AVP) and 5% dextrose in
Lactated Ringer’s.
Two hours after carotid cannulation, the cannula was con-
nected to a fluid-filled pressure transducer (SP844, MEMScAP,
Norway). Animals were conscious and the cannula was long
enough to permit them to move freely in a cage during cardio-
vascular assessment. Beat-to-beat arterial pressure was monitored
using PowerLab and Chart™5 for Windows (ADInstruments, Col-
orado Springs, USA). When blood pressure was stable (typically
5–10 min after connecting the cannula to the transducer), baseline
blood pressure was recorded over 5 min.
The severity of colo-rectal distension (CRD)-induced AD was
examined using a protocol that is well-established in our labora-
tory (Krassioukov and Weaver, 1995). A pediatric silicone balloon-
tipped catheter (10 French; Coloplast, Denmark) was inserted into
the rectum and secured to the tail. After stabilization of arter-
ial pressure, the colon was distended via inflation of 2 ml of air,
over 10 s. Distension was maintained for 1 min; upon deflation of
the balloon, arterial pressure was allowed to recover over 10 min.
Blood pressure was recorded during two episodes of AD in each
animal, with a minimum of 10 min of recovery intervening.
TISSUE PROCESSING AND IMMUNOHISTOCHEMISTRY
Animals were euthanized with an overdose of chloral hydrate
(1 g/kg, i.p.) and perfused through the heart with room tem-
perature phosphate-buffered saline (PBS) followed by cold 4%
paraformaldehyde (PF). Spinal segments and DRGs were removed,
post-fixed in 4% PF for 12 h and cryoprotected in 20% sucrose
in 0.1 M phosphate buffer for ≥24 h. Tissue was embedded
in Tissue Tek (Fisher Scientific, Ottawa, Canada), frozen over
liquid nitrogen, sectioned on a cryostat at 16µm (DRG) or
20µm (cord), thaw-mounted on to glass slides and stored at
−80˚C.
For immunohistochemistry, slides were incubated in 10% nor-
mal donkey serum in PBS plus Triton X-100 (0.1%) for 20 min.
We used five antibodies to delineate different subsets of nocicep-
tors: these included antibodies raised against TRPV1 (Neuromics,
Edina, MN, USA; 1:2,000), the ionotropic ATP purinoceptor P2X3
(Millipore, Billerica, MA, USA; 1:1,000), Substance P (Neuromics,
1:1,000), the glycoprotein isolectin B4 (IB4; Neuromics; 1:2,000),
the glial cell line-derived neurotrophic factor family receptor α 3
(GFRα3; R&D Systems; 1:500). Subsets of non-nociceptive sen-
sory neurons were identified by expression of the vanilloid tran-
sient receptor potential vanilloid-2 (TRPV2; Abcam, Cambridge,
UK; 1:200), parvalbumin (Millipore, Etobicoke, Canada; 1:1,000),
stage-specific embryonic antigen-4 (SSEA-4; Stem Cell Tech-
nologies, Vancouver, Canada; 1:100), and heavy neurofilament
(NF200; Millipore, 1:500). Pan-neuronal markers – microtubule-
associated protein-2 (MAP-2; Abcam, 1:5:000) or β-III-tubulin
(Neuromics; 1:500) – were used to label all neuronal profiles in
the DRG.
All primary antibodies were applied in PBS plus Triton X
overnight. After three 15-min washes in PBS, secondary antibodies
raised in donkey and conjugated to Cy3 (Jackson ImmunoRe-
search, West Grove, USA), Alexa 488 (Invitrogen, Eugene, USA),
or AMCA (7-amino-4-methylcoumarin-3-acetic acid; Jackson
ImmunoResearch) were applied at 1:100–1:400, in PBS-Triton X
for 2 h. Epifluorescent images of DRGs were captured with an
Axioplan 2 microscope (Zeiss, Jena, Germany) with a digital cam-
era (Q Imaging, Burnaby, Canada) and Northern Eclipse software
(Empix Imaging, Inc., Mississauga, Canada). Confocal images of
TRPV1-positive axons in the spinal cord were captured on a spin-
ning disk confocal microscope (an inverted Zeiss AxioObserver
Z.1 equipped with an AxioCam CCD camera). All images for each
antigen used for quantitative analysis were captured at identical
imaging settings.
CARDIOVASCULAR DATA ANALYSIS
Systolic and diastolic blood pressures (SAP and DAP, mmHg)
were obtained from maxima (max) and minima (min) respec-
tively of beat-to-beat blood pressure recordings. Mean arterial
pressure (MAP) was calculated as 1/3max+ 2/3min and heart
rate (HR, beats per minute, bpm) was calculated from inter-
beat interval. Prior to data analysis, raw beat-to-beat blood
pressure data were examined in the Chart view; false max/min
readings created by muscle spasm were manually eliminated
for each animal. Data were analyzed using SigmaPlot (SPSS
Inc., Ashburn, USA). In SigmaPlot, raw pressure and HR val-
ues were averaged over 1 s, such that measurements represent
a 1-s average, not a single beat. For each animal, baseline car-
diovascular parameters represent the average of at least 3 min
of recording time. The CRD-evoked changes in SAP and HR
represent the average of two consecutive distensions for each
animal.
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IMAGE ANALYSIS
All images were analyzed using SigmaScan Pro 5.0 (SPSS Inc.). For
analysis, L4 and L5 DRGs were pooled for each animal (denoted
as L4/L5 throughout) and L6 and S1 DRGs were pooled for each
animal (L6/S1 throughout). The size-frequency distributions of
sensory neurons in the DRG were determined using recursive
translation (Rose and Rohrlich, 1988), which converts neuronal
profiles in section to the cellular population from which they were
drawn (as described previously; Ramer et al., 2001). In five ran-
domly selected sections from each DRG, all neuronal profiles were
traced manually to create an artificial overlay. The average intensity
across the cell body and soma diameter of each neuronal profile
identified by the overlay was measured automatically; soma diam-
eter was defined as Feret diameter, the theoretical diameter of the
object if it were circular in shape. For proportional frequency mea-
surements, the threshold intensity for expression was set manually
for each image. Size-frequency and intensity-frequency distribu-
tions were generated to examine SCI-induced shifts in afferent size
and TRPV1 signal intensity, respectively.
In the spinal cord, measurements of the distribution and inten-
sity of TRPV1-positive axons in the dorsal horn were taken from
tiled confocal projected z-stacks of the L4/L5 and L6/S1 dorsal
horn in cross section. Terminal density was measured as a func-
tion of depth at two sites in the dorsal horn (mid and medial) as
described previously (Ramer et al., 2001, 2004; MacDermid et al.,
2004; Scott et al., 2005). Images were passed through a Laplacian
omnidirectional edge-detection filter, which optimizes the signal-
to-noise ratio and corrects for variations in background staining.
Terminal profiles in filtered images were selected with a threshold
overlay. In order to give all immunopositive pixels equal weight
regardless of brightness, the threshold overlay was treated as a new
image. Density measurements for each animal represent average
density at each depth across five sections.
Density of TRPV1-positive axons in the spinal parasym-
pathetic nucleus was measured from confocal images of the
L6/S1 dorsal gray commissure (DGC). These images were fil-
tered through horizontal and vertical Sobel edge-detection filters,
with the results added through image math prior to thresh-
olding. Density was measured in the spinal parasympathetic
nucleus by selecting an area of gray matter that was centered
on the midline, immediately ventral to the dorsal corticospinal
tract and rostral to the central canal. Density measurements
for each animal represent average density across three to five
sections.
STATISTICS
For cardiovascular data, baseline parameters and stimulus-evoked
changes were compared among groups using a one-way analy-
sis of variance (ANOVA). The Holm–Sidak Test was used for
pair-wise comparisons when significant differences were detected.
For size distribution data from the DRG, Kolmogorov–Smirnov
(K–S) goodness-of-fit tests were used to determine whether neu-
ronal cumulative size-frequency distributions differed between
groups (sham- versus spinal cord-injured). Proportions of neu-
rons labeled with each antigen were compared using Student’s
t -test. The K–S goodness-of-fit test was also used to detect inter-
group differences in cumulative intensity-frequency distributions
of TRPV1-expressing cells in the DRG. Density of TRPV1-positive
terminals in the dorsal horn of sham- and spinal cord-injured
animals was compared using a one-way ANOVA on ranks, fol-
lowed by Dunn’s test to detect pair-wise differences. Density of
TRPV1-positive terminals in the DGC of sham-injured and SCI
rats was compared between groups using Student’s t -test. In
assessing the effects of early and late intrathecal capsaicin on
TRPV1 axons in the DGC, a one-way ANOVA was used. For
all physiological and anatomical analyses, group averages rep-
resent five to seven animals per group, results are expressed as
mean± standard error of the mean (SEM), image, and data analy-
ses were performed in a blinded fashion (using coded image
and data files) and P values less than 0.05 were considered
significant.
RESULTS
COMPLETE HIGH-THORACIC SPINAL CORD INJURY PROVOKED
HYPERTROPHY IN SENSORY NEURONS THAT EXPRESS THE CAPSAICIN
RECEPTOR
Neuronal phenotype, of which size is a defining characteristic,
is governed in large part by trophic influences of target tissues.
These undergo profound changes following SCI, including atro-
phy of skeletal muscle and bladder hypertrophy. Therefore, we
examined changes in the size distribution of all sensory neurons
in lumbosacral DRGs 3 months after T3 complete SCI. Neuronal
profiles in the L4/L5 DRG were labeled with neuron-specific β-III-
tubulin (Figure 1A) and size-frequency analysis was performed
following recursive translation (Figure 1B). There was a subtle
but statistically significant right-shift (i.e., hypertrophy) in the size
distribution of all sensory neurons in DRGs of animals with T3
SCI.
We next sought to determine which population(s) of sensory
neurons responded to T3 SCI. We began by examining subsets of
small-diameter sensory neurons in the L4/L5 DRG (Figure 2). Pep-
tidergic (NGF-sensitive) nociceptors were identified by expression
of Substance P (SP; Figure 2A), while non-peptidergic noci-
ceptors were identified by binding of the glycoprotein isolectin
B4 (IB4, from Bandeiraea simplicifolia) and the ionotropic ATP
purinoceptor P2X3 (Figures 2B,C). At 3 months after T3 SCI, nei-
ther of these minimally overlapping populations of nociceptors
exhibited hypertrophy after T3 SCI, suggesting that sensory hyper-
trophy caudal to T3 SCI was selective to another subset of sensory
neurons.
In rats, TRPV1 expression occurs in subsets of both peptidergic
and non-peptidergic nociceptors (Tominaga et al., 1998). TRPV1
expression also defines a subpopulation of neurons which are nei-
ther P2X3-expressing/IB4-binding nor neuropeptide-expressing
(Michael and Priestley, 1999). When we examined the size dis-
tribution of TRPV1-positive neurons in the L4/L5 DRG, we found
a pronounced hypertrophy in DRGs from animals with T3 SCI
(Figure 2D). TRPV1-positive cells increased in size after SCI, but
their proportional frequency did not change (Figure 2D, inset).
Approximately 50% of TRPV1-positive sensory neurons also
express the artemin-specific glial cell line-derived neurotrophic
factor family member GFRα3 (Baloh et al., 1998; Bennett et al.,
2006). GFRα3-positive sensory neurons (of which >80% express
TRPV1; Bennett et al., 2006) also exhibited hypertrophy, in the
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FIGURE 1 | High-thoracic (T3) spinal cord injury provoked hypertrophy
of neurons in the L4/L5 dorsal root ganglion. (A) βIII-tubulin
immunohistochemistry illustrating neuronal profiles in the L5 DRG. (B)
Size-frequency distribution of pooled L4/L5 DRG neurons, reconstructed
from profile distributions using recursive translation. Ganglia were
harvested 3 months after sham-injury (gray) or complete T3 SCI (black).
There was a small but significant rightward shift in size-frequency
distribution in animals with T3 SCI (P <0.05, K–S goodness-of-fit test).
Scale bar=70µm.
absence of change in proportional frequency, in DRGs distal to T3
SCI (Figure 2E).
We performed size-frequency analysis on medium-to-large sen-
sory neurons in the same (L4/L5) DRGs by examining neurons
expressing heavy neurofilament (NF200; Figure 3). At 3 months
after T3 SCI, there was no evidence of injury-induced hypertro-
phy in NF200-positive cells, nor did the proportion of NF200-
expressing cells change (Figure 3A). In agreement with previous
findings (e.g., Yamamoto et al., 2008), we found that the large
majority of TRPV1-positive neurons were NF200-negative; only
occasional neurons co-expressed TRVP1 and NF200 (Figure 3B,
arrow). The extent of TRPV1 and NF200 co-expression did not
increase after T3 SCI (Figure 3B).
To confirm that SCI-induced hypertrophy was specific to small-
diameter DRGs, we also performed size-frequency analysis on
three subpopulations of medium-to-large sensory neurons in the
L4/L5 DRG (data not shown). Expression of TRPV2 was used to
identify larger sensory neurons that are heat-sensitive but TRPV1-
negative (Caterina et al., 1999; Tamura et al., 2005). Proprioceptors
and cutaneous mechanoreceptors were labeled with parvalbumin
(Celio, 1990) and SSEA-4 (Dodd et al., 1984), respectively. In con-
trast to SCI-induced hypertrophy in TRPV1-expressing nocicep-
tors, there were no detectable changes in the size distributions of
these subpopulations of medium- to-large DRG neurons following
T3 SCI.
SPINAL CORD INJURY-INDUCED HYPERTROPHY WAS MOST
PRONOUNCED IN LUMBOSACRAL SENSORY GANGLIA
Since our initial observations were made in DRGs far distal to
T3 SCI (Figures 1–3, L4/L5 DRG), we examined the extent of
SCI-induced hypertrophy in TRPV1-positive neurons at differ-
ent rostro-caudal levels (Figure 4). We examined tissue harvested
1 month after T3 durotomy (sham-injury) or SCI (Figures 4–6).
Of the levels examined, SCI-induced hypertrophy was restricted to
ganglia below the injury: TRPV1-positive afferents did not exhibit
hypertrophy in the T1 DRG, despite their proximity to the injury
site (Figure 4A). Equidistant but caudal to SCI (in the T5 DRG),
the size distribution of TRPV1-positive sensory neurons was right-
shifted relative to sham-injured controls (Figure 4B). However,
the effect of SCI was most dramatic in lumbosacral DRGs, remote
from the site of injury. TRPV1-positive cells exhibited pronounced
hypertrophy in both L4/L5 and L6/S1 DRGs (Figures 4C,D). The
rightward shift in size distribution was most dramatic in L6/S1
DRGs, containing afferents innervating the urinary bladder and
the distal colon (Nadelhaft and Booth, 1984).
CAPSAICIN-SENSITIVE AFFERENTS HYPERTROPHIED AND
UPREGULATED THE CAPSAICIN RECEPTOR AFTER SPINAL CORD
INJURY
While there was no change in the proportion of sensory neurons
expressing TRPV1 after T3 SCI, this does not negate an intra-
cellular upregulation of TRPV1. To investigate this possibility,
we examined the intensity of TRPV1 expression in lumbosacral
DRGs. Sections of L4/L5 and L6/S1 DRG from sham-injured
controls and animals with T3 SCI were processed for TRPV1
immunohistochemistry and examined at the microscope by a
blinded investigator, with all imaging parameters (exposure time,
gain, and offset) set at constant levels across groups. With identical
immunohistochemical processing and imaging, there was an obvi-
ous increase in intensity of TRPV1 expression in DRGs from ani-
mals with SCI (Figure 5). This was confirmed through blind quan-
tification: when images were processed to generate size-intensity
distributions of TRPV1-positive neuronal profiles, the intensity
distribution in DRGs from animals with T3 SCI was right-shifted
relative to sham-injured controls (Figures 5A,B). Akin to SCI-
induced hypertrophy, the shift in TRPV1 signal intensity was most
pronounced in the L6/S1 DRGs.
INJURY-INDUCED HYPERTROPHY WAS MODEST AFTER
LOW-THORACIC SPINAL CORD INJURY
The large majority of work in animal models of SCI examines
injury-induced changes after low-thoracic SCI (Ramsey et al.,
2010). For example, data describing SCI-induced changes in
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FIGURE 2 | High-thoracic (T3) spinal cord injury-induced selective
hypertrophy of sensory neurons expressing the capsaicin receptor
(TRPV1) and the artemin receptor (GFRα3) in the L4/L5 DRG. (A)
Substance P (SP) – positive DRG neurons and their size-frequency
distributions. (B) IB4-binding DRG neurons. (C) P2X3-positive DRG neurons.
(D) TRPV1-positive DRG neurons. (E) GFRα3-expressing DRG neurons, known
to express TRPV1. The overall proportions of immunopositive neurons [insets
(A–E)] did not change for any subpopulation. Ganglia were harvested
3 months after sham-injury (gray) or complete T3 SCI (black). Scale
bar=50µm. Asterisks indicate P <0.05, K–S goodness-of-fit test.
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FIGURE 3 | High-thoracic (T3) spinal cord injury had no effect on
medium-to-large sized neurons in the L4/L5 DRG expressing heavy
neurofilament (NF200). (A) NF200-positive neurons did not undergo
SCI-induced hypertrophy, nor did the proportion of neurons expressing NF200
change. (B) Hypertrophy of TRPV1-expressing DRG neurons was not
accompanied by increased co-localization of TRPV1 and NF200. Ganglia were
harvested 3 months after sham-injury (gray) or complete T3 SCI (black). Arrow:
DRG neuron immunopositive for both TRPV1 and NF200. Scale bar=70µm.
DRGs with bladder-projecting afferents (L6/S1), in the absence
of changes in DRGs with somatic afferents (L4/L5), were derived
from rats with low-thoracic SCI (Zvarova et al., 2005). We there-
fore examined the size distribution of TRPV1-positive afferents
in lumbosacral DRGs from animals with T10 complete SCI
(Figure 6). One month after T10 complete SCI, TRPV1-positive
neurons did not exhibit hypertrophy in L4/L5 DRGs; size distrib-
ution of TRPV1-expressing neurons was similar between animals
with T10 SCI and sham-injured controls (sham; Figure 6A).
In the L6/S1 DRGs, there was a small but significant rightward
shift in the size distribution of TRPV1-positive neurons after T10
SCI (Figure 6B). Interestingly, hypertrophic changes induced by
low-thoracic SCI were much less dramatic than those triggered
by T3 SCI (compare Figures 6B and 4D). This was surprising,
given that both injuries induce hind limb paralysis and LUT
dysfunction.
DRAMATIC SOMATIC HYPERTROPHY IN CAPSAICIN-SENSITIVE
AFFERENTS WAS NOT REFLECTED IN PLASTICITY OF THEIR CENTRAL
PROJECTIONS
Multiple studies have demonstrated that severe SCI triggers
intraspinal sprouting of nociceptors (Krenz and Weaver, 1998;
Weaver et al., 2001) and that sprouting of CGRP-expressing
afferents in the dorsal horn is correlated with severity of AD
(Krenz et al., 1999; Cameron et al., 2006). SCI also prompts a
subset of DRG neurons, those expressing the pituitary adenylate
cyclase activation peptide (PACAP), to expand their territory in
the lumbosacral dorsal horn in segments containing visceral cir-
cuitry (L1, L2, L6, and S1; Zvarova et al., 2005). Since PACAP and
CGRP partially co-localize with TRPV1 in DRG neurons (Moller
et al., 1993), we measured the density of TRPV1-expressing ter-
minals in the L4/L5 and L6/S1 dorsal horn, the central projections
of afferents exhibiting the most pronounced hypertrophy after
T3 SCI. Working from tiled mosaics of confocal z-stack projec-
tions (Figure 7A), we detected a slight but significant increase
in density of TRPV1-positive terminals in the superficial laminae
at two locations in the L4/L5 dorsal horn. Density of TRPV1-
positive projections was increased superficially, in lamina I of the
lateral dorsal horn and lamina II–III of the medial dorsal horn.
There was no evidence of TRPV1-positive afferents sprouting into
deeper laminae after SCI. There was also no difference in density
of TRPV1-expressing afferents in the L6/S1 dorsal horn between
sham-injured animals and animals with T3 SCI (Figure 7B). These
results indicate that the CGRP- and PACAP-positive axons which
were previously shown to sprout after SCI are not those which
contain TRPV1.
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We also examined density of TRPV1-positive projections to the
DGC in the L6/S1 spinal cord, a region that receives input from
visceral afferents, including those in the distal colon (Morgan et al.,
1981; Hou et al., 2009). Densitometric analysis demonstrated that
there was no effect of SCI on projections to the DGC (Figure 7B).
Since we were working from cross-sections of spinal cord, we did
not attempt quantitative measurements of TRPV1-positive projec-
tions to the lateral parasympathetic preganglionic nucleus (which
is rostro-caudally periodic in the lumbosacral spinal cord; Mor-
gan et al., 1981). There were no qualitatively apparent changes
in the density of TRPV1-positive projections to parasympathetic
preganglionic neurons after T3 SCI.
INTRATHECAL CAPSAICIN ATTENUATED COLO-RECTAL
DISTENSION-INDUCED AUTONOMIC DYSREFLEXIA
The dramatic effects of T3 SCI on TRPV1-expressing afferents in
L6/S1 DRGs prompted us to examine their contribution to the
development of AD (Figure 8). We administered 50µg of cap-
saicin in a single intrathecal injection at the L4 spinal cord, 28 days
after T3 SCI (“late Cap.”) or 48 h after T3 SCI (“early Cap.”).
Since TRPV1-positive sensory neurons exhibit spontaneous activ-
ity de novo as early as 24 h following SCI (Bedi et al., 2010), we
hypothesized that early capsaicin treatment might have particu-
larly pronounced effects on development of AD. Vehicle injections
(“Veh.”) were performed 28 days after SCI.
Consistent with previous findings, capsaicin injection pro-
duced a permanent degeneration of spinally projecting TRPV1-
positive axons (Figure 8A; Yaksh et al., 1979). Efficacy of capsaicin
was confirmed via densitometric measurements within the DGC
(Figure 8A), which demonstrated a rapid and sustained depletion
of TRPV1-positive projections. At 30 days after T3 SCI, carotid
cannulae were implanted for beat-to-beat blood pressure measure-
ments (Figure 8B). Capsaicin injection had no effects on blood
pressure or HR at rest (Figure 8C). Animals that received capsaicin
after T3 SCI exhibited much less severe AD in response to CRD
(Figure 8C). There was no effect of differential timing of capsaicin
injection following SCI: early and late capsaicin treatment pro-
duced equivalent reductions in CRD-induced hypertension and
bradycardia. In both groups, the CRD-evoked change in SAP was
reduced by approximately 50% relative to vehicle-treated animals,
and CRD-induced bradycardia was dramatically attenuated.
DISCUSSION
These experiments demonstrate injury-induced hypertrophy in
a specific subset of TRPV1-positive sensory neurons caudal to
SCI. The response was most pronounced in lumbosacral DRGs
and after high-thoracic SCI. Finally and notably, eliminating the
central projections of TRPV1-expressing axons after T3 SCI via
intrathecal capsaicin injection had pronounced mitigating effects
on the severity of CRD-induced AD. Here we discuss the poten-
tial mechanisms of this SCI-provoked hypertrophy, its relation-
ship to level of injury and the relevance for sensory-autonomic
dysfunction following SCI.
SPINAL CORD INJURY-INDUCED HYPERTROPHY WAS RESTRICTED TO
A SUBSET OF CAPSAICIN-SENSITIVE NEURONS
The selectivity of sensory neuron hypertrophy following SCI pro-
vides important clues about the underlying trophic mechanism.
FIGURE 4 | Capsaicin-sensitive dorsal root ganglion neurons increased
in diameter caudal to, but not rostral to, high-thoracic spinal cord
injury. (A–D) Size-frequency distributions of TRPV1-positive neurons from a
rostral DRG (T1) and caudal (T5, L4/L5, L6/S1) DRGs, harvested 1 month
after sham- (gray) or complete T3 SCI (black). The increase in size is the
most pronounced in the most caudal ganglia. Proportions of TRPV1-positive
neurons at each level are shown in the insets (A–D). Asterisks indicate
P <0.05, K–S goodness-of-fit test.
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FIGURE 5 | Capsaicin-sensitive neurons in the dorsal root ganglion
exhibited increasedTRPV1 signal intensity following high-thoracic spinal
cord injury. (A) Size-intensity scatter plots of TRPV1-positive DRG neurons
showing a marked upward scatter with T3 SCI. The increase in TRPV1
intensity was particularly pronounced in L6/S1 DRGs. There was a significant
increase in signal intensity at 3 months after T3 SCI for both L4/L5 DRGs and
L6/S1 DRGs (K–S goodness-of-fit tests on cumulative intensity-frequency
distributions). (B) Representative images of TRPV1-expression in the L6/S1
DRG, from a sham-injured control (top) and an animal with T3 SCI (bottom).
Scale bar=50µm.
While the results demonstrate T3 SCI-induced hypertrophy of
TRPV1-positive DRG neurons, it is clear that this is not univer-
sally true: that is, there must be a specific subset of TRPV1 neurons
which responds to SCI by increasing in size. This assertion is
based on the fact that a rightward shift in size-frequency distri-
bution is detectable in the analysis of all (βIII-tubulin-labeled)
neurons (Figure 1), but not for IB4/P2X3 or SP subpopulations
(Figure 2), each of which partially co-localizes with TRPV1 (Tom-
inaga et al., 1998). Thus, the TRPV1-expressing neurons of interest
express neither standard peptidergic nor non-peptidergic nocicep-
tor markers (Michael and Priestley, 1999); these would have been
included in the analysis of βIII-tubulin-positive profiles (i.e., all
DRG neurons), but omitted from those involving SP, P2X3, and
IB4-positive cells. Thus,hypertrophy is largely or entirely restricted
to a unique population of TRPV1-expressing neurons.
Analysis of neurons expressing GFRα3 (∼85% of which co-
express TRPV1; Bennett et al., 2006) provides a further clue to
the identity of this specific subset of nociceptors. The hyper-
trophic neurons are most likely sensitive to artemin, a GDNF
family neurotrophic factor. Previous experiments have shown that
peripheral over-expression of artemin in mouse keratinocytes
not only leads to hypertrophy of DRG neurons, but also to
upregulation of TRPV1 mRNA and increased capsaicin sensi-
tivity (Elitt et al., 2006). Artemin is therefore a likely candidate
for inducing hypertrophy following SCI. While there are no data
describing expression of endogenous artemin after SCI, the pattern
of injury-induced hypertrophy is suggestive.
SPINAL CORD INJURY-INDUCED HYPERTROPHY WAS PARTICULARLY
DRAMATIC IN CAUDAL GANGLIA, FAR DISTAL TO INJURY
The ganglia in which size changes occurred also give cause for
speculation on the molecular underpinnings of this response to
injury. The inflammatory response to SCI is prolonged and well-
characterized (Alexander and Popovich, 2009). The character of
the inflammatory milieu evolves over time and is accompanied by
production of cytokines and trophic factors which could act on
the ganglia attached to the cord to induce hypertrophy. However,
injury-induced hypertrophy was absent or modest in T1 and T5
DRGs (respectively) which argues against a central role for a factor
produced at the site of SCI.
Pronounced hypertrophy occurred far distal to the site of T3
SCI, in lumbosacral DRGs. Interestingly, TRPV1-positive somata
were enlarged in DRGs supplying predominately somatic (L4/L5)
and predominately visceral (L6/S1) peripheral targets. This sce-
nario represents a departure from the phenotypic changes that
are restricted to visceral afferents after low-thoracic injury (Kruse
et al., 1995; Qiao and Vizzard, 2002). TRPV1-expressing sensory
neurons innervate skin, epithelia (notably in the bladder), and
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FIGURE 6 | Low-thoracic (T10) spinal cord injury elicited only modest
changes in size of the most caudal capsaicin-sensitive dorsal root
ganglion neurons. (A) No difference in size distributions of
TRPV1-expressing DRG neurons in L4/L5 DRGs. (B) There was a small but
significant rightward shift in the size-frequency distribution of L6/S1 DRG
neurons (P <0.05, K–S goodness-of-fit test), but this was much less
dramatic than that which occurred after T3 SCI (see Figure 4). Ganglia were
harvested 1 month after sham (gray) or complete T3 SCI (black).
both skeletal and smooth muscle in a variety of targets, including
the colon and the bladder (Willis, 2007; Everaerts et al., 2008;
Malin et al., 2011; Skryma et al., 2011; Yu et al., 2011). The
structure and function of these target tissues are dramatically
altered following SCI. Paralyzed skeletal muscle undergoes rapid
and profound atrophy (Qin et al., 2010). In contrast, the smooth
(detrusor) muscle of the bladder becomes hypertrophic over time
following supraconal SCI, due to the combined effects of detru-
sor hyperactivity and detrusor-sphincter dyssynergia (Yoshimura,
1999). The bladder epithelium is also altered in chronic SCI (Smith
et al., 2008). Less is known about remodeling of smooth muscle
in the lower gastrointestinal (GI) tract after SCI. However, given
the pronounced changes in lower GI function after SCI, includ-
ing increased transit time that manifests clinically as constipation
(Brading and Ramalingam, 2006), it seems reasonable to speculate
that intrinsic smooth muscle of the distal colon also undergoes
inactivity-induced remodeling following injury. The same logic
applies to skin below the injury: while there are few data describing
structural changes in skin, pressure ulcers are a common compli-
cation of SCI (Cardenas et al., 2004; Gelis et al., 2009). In view of
the diverse changes in peripheral targets of TRPV1-positive lum-
bosacral DRG afferents after SCI, it is very likely that these afferents
are exposed to different (or different amounts of) neurotrophic
factors post-injury.
INJURY-INDUCED HYPERTROPHY WAS NOT ACCOMPANIED BY
PRONOUNCED INTRASPINAL SPROUTING
The pronounced somatic hypertrophy in TRPV1-expressing affer-
ents was not accompanied by an equally dramatic expansion
of their central terminals in the spinal dorsal horn. Previous
findings indicate that low-thoracic SCI prompts an increase in
TRPV1 mRNA, but a reduction in TRPV1 expression demon-
strated immunohistochemically, at and around the site of injury
(DomBourian et al., 2006). Distal to SCI, the only available data
report that there is no change in spinal distribution of TRPV1-
positive projections after low-thoracic injury (Cruz et al., 2008).
We observed a relatively minor increase in density that was
restricted to the superficial laminae of the L4/L5 dorsal horn
after T3 SCI. While somatic hypertrophy and axonal sprouting
do not necessarily occur together, most trophic factors are capa-
ble of eliciting both. For example, in bladder afferents caudal
to low-thoracic SCI, bladder-, and/or spinal cord-derived NGF
is thought to mediate somatic hypertrophy (Yoshimura, 1999;
Seki et al., 2002; Yoshimura et al., 2006), and intraspinal NGF
also contributes to SCI-induced sprouting of peptidergic noci-
ceptors in the dorsal horn (Christensen and Hulsebosch, 1997;
Krenz et al., 1999; Cameron et al., 2006). In contrast to the dis-
tribution of CGRP-positive terminals in the dorsal horn caudal to
high-thoracic SCI (Ondarza et al., 2003), TRPV1-positive affer-
ents did not invade deeper laminae of the dorsal horn. In these
experiments, we demonstrate something quite different after SCI:
afferents that are constitutively present in the spinal dorsal horn
undergo dramatic hypertrophy and receptor upregulation at the
level of their soma (i.e., in the periphery). While the majority of
data describe dramatic changes within the spinal cord caudal to
high-thoracic SCI, creating the potential for altered connectivity
within central sensory-sympathetic circuits, we demonstrate pro-
nounced effects in the periphery. The potential for pathological
sensory-sympathetic interactions in the periphery exists, and may
also contribute to AD (Ramer et al., 2006). The absence of robust
sprouting of TRPV1 axons in the spinal cord suggests that the
stimulus is also peripheral, possibly in the DRG itself. An intra-
ganglionic source of artemin, for example, might be satellite cells
in the DRG: artemin is expressed in Schwann cells, which are phe-
notypically similar to satellite cells, and is upregulated in Schwann
cells after peripheral nerve injury (Baloh et al., 1998).
INJURY-INDUCED HYPERTROPHY WAS MORE PRONOUNCED AFTER
HIGH-THORACIC THAN LOW-THORACIC SPINAL CORD INJURY
The differential effects of complete SCI at T3 and T10 are interest-
ing, given the similarities in many aspects of functional outcome.
For example, T3 and T10 SCI induce hind limb paralysis and
bladder dysfunction that is grossly similar: the bladder is initially
areflexic and requires manual emptying until reflexive micturition
is restored. The issue of LUT function is certainly relevant, since
TRPV1-positive sensory neurons are critically involved in physio-
logical bladder function (Araki, 2011) and appear to contribute
to bladder dysfunction after SCI (Cruz et al., 2008). TRPV1-
expressing afferents also mediate a number of pathological phe-
nomena in the LUT, including bladder pain and overactive bladder
(Eid, 2011; Kissin and Szallasi, 2011); recent findings suggest that
these afferents also participate in pelvic organ cross-sensitization
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FIGURE 7 | Hypertrophy of capsaicin-sensitive afferents caudal to
high-thoracic spinal cord injury was not accompanied by pronounced
plasticity of their spinal projections. (A) One month after T3 complete
SCI, there was a small but significant increase in TRPV1-positive axon
density in the medial (med.) and lateral (lat.) parts of the most superficial
laminae of the L4/L5 dorsal horn (boxed regions are shown enlarged).
There was no evidence of TRPV1-positive axon extension into deeper
laminae. (B) In the L6/S1 cord, there were no differences between
sham-injured or T3 SCI animals in the dorsal horn, or in the dorsal gray
commissure (DGC, boxed image enlarged to the right), the terminal field
of the visceral medial collateral pathway. Asterisks: P <0.05, Student’s
t -test. Scale bars=200µm.
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FIGURE 8 | Intrathecal capsaicin attenuated colo-rectal distention (CRD)
-induced autonomic dysreflexia in animals that survived for 1 month
after completeT3 spinal cord injury. (A) A single intrathecal bolus of
capsaicin (10µl of 5 mg/ml in 50% DMSO) resulted in permanent
degeneration of spinally projecting TRPV1-positive axons. Quantification
shows TRPV1 axon density in the dorsal gray commissure (DGC). Asterisk
indicates significant difference between vehicle-treated T3 SCI animals and
both capsaicin-treated groups (P <0.05, one-way ANOVA). Scale
bar=200µm. (B) Beat-to-beat changes in blood pressure in response to
colo-rectal distension (horizontal bars) from animals treated with intrathecal
vehicle (Veh.), early capsaicin (48 h following T3 SCI, early Cap.), and late
capsaicin (48 h prior to physiological recording, 28 days post-T3 SCI, late Cap.).
(C) Quantitative cardiovascular responses to CRD in vehicle and
capsaicin-treated rats, 30 days post-SCI. Capsaicin treatment, whether
administered 48 h or 28 days after SCI, mitigated CRD-induced increases in
systemic arterial pressure (SAP) and decreases in heart rate (HR). Resting
SAP and HR were unaffected by intrathecal capsaicin. Asterisks: P < 0.05,
one-way ANOVA.
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(Asfaw et al., 2011). However, SCI-induced changes were not
restricted to bladder afferents after T3 SCI, since hypertrophy was
also apparent in L4/L5 DRGs. One explanation might be that sig-
nals from the hypertrophic bladder contribute to injury-induced
hypertrophy, but the predominant trigger is present in high-, but
not low-thoracic SCI.
One notable difference in high- versus low-thoracic SCI that
has been identified lies in the immune response to injury. In mice,
immune suppression induced by SCI is level-dependent, such that
mice with T3 SCI exhibit impaired antibody synthesis and elevated
splenic norepinephrine, neither of which develop in mice with T9
injury (Lucin et al., 2007). If level-dependent immune suppres-
sion also occurs in rats with SCI, the inflammatory response in
the DRG may also vary with level of injury, influenced by sys-
temic activity of the immune system. The limited data that are
available describe immune cell infiltration in DRGs caudal to T8
SCI (McKay and McLachlan, 2004): in this study, intra-ganglionic
immune cell density was highest in DRGs closer to the lesion site
(i.e., greater in T12 DRGs than in L6 DRGs). This pattern does
not seem to fit with our results, but may be different after T3 SCI;
alternatively, other factors modifying the environment of the DRG
(such as satellite cells activation) may not vary in step with the local
immune response.
The most dramatic difference in the functional outcomes of T3
and T10 SCI is the development of AD after the former, but not
the latter injury. In AD, sensory stimulation evokes sympathetic
contractions of vascular smooth muscle. It is not insignificant
that artemin is developmentally expressed in vascular smooth
muscle where it acts as a guidance cue for sympathetic (and
probably also sensory) axons (Honma et al., 2002). In essential
hypertension, chronic constriction of the blood vessels induces
maladaptive remodeling of the vasculature (Rizzoni et al., 2007,
2009; Rehman and Schiffrin, 2010). Remodeling resulting in an
increase in media-lumen ratio can occur via different mecha-
nisms, including rearrangement of the same wall material around a
narrowed lumen (eutrophic remodeling) or vascular smooth mus-
cle cell growth (hypertrophic remodeling; Intengan and Schiffrin,
2001). While less is known about the effects of intermittent or
episodic hypertension on vascular structure, one recent study
indicates that carotid intima-media thickness is increased in indi-
viduals with SCI (Matos-Souza et al., 2009). The possibility of
artemin upregulation in vascular smooth muscle has yet to be
explored, but may contribute to the more pronounced hypertro-
phy of TRPV1/GFRα3 neurons following T3 SCI compared to
injury at T10. TRPV1-positive afferents have collateral branches
that supply blood vessels, particularly arterioles, in the submucosa
of the gastrointestinal (GI) tract (Holzer, 2006). The vasculature
of the GI tract is part of the splanchnic bed that is critically
involved in blood pressure control, including the development
of AD (Lujan et al., 2010): these arteries are known to be altered
after high-thoracic SCI (Brock et al., 2006; Alan et al., 2010).
CAPSAICIN-SENSITIVE AFFERENTS CONTRIBUTED SUBSTANTIALLY TO
COLO-RECTAL DISTENSION-INDUCED AUTONOMIC DYSREFLEXIA
Selective elimination of TRPV1-expressing afferents in the spinal
dorsal horn dramatically reduced the severity of AD. Peripheral
projections of TRPV1-positive afferents in the DRGs innervating
the rectum and distal colon are found in smooth muscle and the
mucosa and are mechanosensitive and/or chemosensitive (Lynn
and Blackshaw, 1999; Berthoud et al., 2001; Ward et al., 2003).
Neurons in the capsaicin-sensitive, mechanosensitive subset are
known to respond to CRD (Brierley et al., 2005). Intrathecal
capsaicin injected at L4 eliminated the central projections of
TRPV1-positive spinal colonic afferents, which constitute approx-
imately 50% of the lumbosacral colonic DRG neurons (Brierley
et al., 2005). This is reflected in our data, demonstrating that
CRD following intrathecal capsaicin injection still activates a sub-
set of mechanosensitive afferents to elicit AD, although AD is
dramatically reduced in severity (Figure 8).
We hypothesized that early elimination of TRPV1-expressing
afferents would have even more pronounced effects on AD (than
late capsaicin, administered at 28 days post-SCI). This premise
was based in part on recent findings demonstrating spontaneous
activity arising in the soma develops in DRGs after SCI (Bedi
et al., 2010). There are several striking similarities between the
patterns of de novo spontaneous activity and hypertrophy that
emerge following SCI. Both phenomena develop caudal, but not
rostral to SCI, and are most pronounced in distal DRGs, remote
from the site of injury. Both occur in nociceptors, and most
intriguingly, a high percentage of the afferents that exhibited
spontaneous activity after T10 SCI were capsaicin-sensitive (Bedi
et al., 2010). Cumulatively, these findings suggest that SCI has spe-
cific effects on TRPV1-expressing primary afferents. In bladder
afferents, SCI-induced somatic hypertrophy is accompanied by
increased excitability, including reduced thresholds for activation
(Yoshimura, 1999). If hypertrophy is an anatomical surrogate for
spontaneous activity after SCI, injury-induced ongoing activity in
TRPV1-positive neurons might be more even more pronounced
and/or prevalent after T3 SCI.
However, early and late capsaicin treatment had equivalent
effects on AD (Figure 8B). From these findings, we cannot reli-
ably determine whether TRPV1-positive afferents only instigate
CRD-evoked AD, or both instigate AD and contribute to its devel-
opment over time following SCI. A reversible TRPV1-block might
distinguish between these two possibilities. Given the evidence for
spontaneous activity in capsaicin-sensitive afferents caudal to SCI,
this is a future direction with important clinical implications for
AD, and potentially for pain.
CONCLUSION
Previous work has identified numerous mechanisms that might
contribute to induction and progression of AD,and the list of puta-
tive mechanisms includes injury-induced changes in the vascula-
ture and multiple components of the spinal sensory-sympathetic
circuitry caudal to SCI (Krenz and Weaver,1998; Krassioukov et al.,
1999; Krenz et al., 1999; Brock et al., 2006; McLachlan and Brock,
2006). In terms of sensory plasticity, prior findings demonstrate
that severity of AD is closely correlated to the extent of intraspinal
nociceptor sprouting (Cameron et al., 2006). However, this is the
first study to demonstrate AD mediated by a specific subset of
afferents that exhibit pronounced somatic, but only slight central,
injury-induced plasticity. Given the array of pronounced changes
in peripheral targets of sensory neurons after SCI, it is not surpris-
ing that they respond to injury. Plasticity occurring outside the
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CNS may represent a new and more accessible target for limiting
sensory-autonomic dysfunction following SCI.
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